The evolution of Alzheimer’s disease: From mitochondria to microglia
Ageing Research Reviews · 2025-09 · 111 · 102838
DOI: 10.1016/j.arr.2025.102838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025-09. Verfasst von Feng-Ge Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Electronic address: 15638455330@163.com. Hauptthemen laut MEDLINE: Alzheimer Disease, Microglia, Mitochondria. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 183 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) represents the most prevalent neurodegenerative disorder worldwide. Recent studies highlights that mitochondrial dysfunction drives alterations in microglial function, serving as a pivotal mechanism in the pathogenesis and progression of AD. Increasingly, there is evidence that mitochondrial dysfunction encompasses energy metabolism deficits, heightened oxidative stress, impaired mitochondrial dynamics, disrupted autophagy, and calcium homeostasis imbalances. These impairments modulate microglial activation states, precipitating exacerbated neuroinflammation, altered phagocytic capacity, and increased cellular apoptosis, collectively contributing to microglial dysfunction. This paper presents a narrative review on the relationship between mitochondrial dysfunction and AD, elucidating the impact of mitochondrial impairment on microglia. It summarizes therapeutic strategies that target mitochondria to modulate microglial function, aiming to prevent and treat AD. The goal is to provide new perspectives and insights for AD research and treatment, contributing to improving patients' quality of life and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Electronic address: 15638455330@163.com.
- The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Electronic address: 675239834@qq.com.
- The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Electronic address: 1779641824@qq.com.
- The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Electronic address: Yfg18646330657@yeah.net.
- Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China; Jiangsu College of Nursing, Huaian, Jiangsu, China. Electronic address: youfengbo1112@163.com.
- Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Electronic address: 18808234240@163.com.
Zitieren
APA
Yang, F. G., Liang, Y. L., Wang, X., Wang, J. T., Gao, W., Ye, Q. Y., Li, X. Y., Yang, Y., & Li, H. L. (2025). The evolution of Alzheimer’s disease: From mitochondria to microglia. Ageing Research Reviews, 111, 102838. https://doi.org/10.1016/j.arr.2025.102838
Vancouver
Yang FG, Liang YL, Wang X, Wang JT, Gao W, Ye QY, et al. The evolution of Alzheimer’s disease: From mitochondria to microglia. Ageing Research Reviews. 2025;111:102838. doi:10.1016/j.arr.2025.102838
BibTeX
@article{Yang2025,
author = {Yang, Feng-Ge and Liang, Yu-Lin and Wang, Xu and Wang, Jun-Ting and Gao, Wei and Ye, Qiu-Yan and Li, Xue-Yuan and Yang, Yu and Li, Hong-Lin},
title = {The evolution of Alzheimer’s disease: From mitochondria to microglia},
journal = {Ageing Research Reviews},
year = {2025},
volume = {111},
pages = {102838},
doi = {10.1016/j.arr.2025.102838}
}
EUVIMED